Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.

Montes A, Perez-Pampin E, Calaza M, Gomez-Reino JJ, Gonzalez A.

Arthritis Rheum. 2013 Feb;65(2):542. doi: 10.1002/art.37743. No abstract available.

2.

Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.

van der Woude D, Scherer HU, Huizinga TW, Toes RE.

Arthritis Rheum. 2013 Feb;65(2):541-2. doi: 10.1002/art.37744. No abstract available.

3.

Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis.

Montes A, Perez-Pampin E, Calaza M, Gomez-Reino JJ, Gonzalez A.

Arthritis Rheum. 2012 Oct;64(10):3102-10. doi: 10.1002/art.34569.

4.

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.

Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.

Arthritis Rheum. 2010 Jan;62(1):44-52. doi: 10.1002/art.25036.

5.

An intriguing relationship between the immune response to citrullinated vimentin and the HLA shared epitope: comment on the article by Verpoort et al.

Bell DA, Hill JA, Cairns E.

Arthritis Rheum. 2008 Oct;58(10):3277; author reply 3277-8. doi: 10.1002/art.23947. No abstract available.

6.

Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.

Rodríguez-Mahou M, López-Longo FJ, Sánchez-Ramón S, Estecha A, García-Segovia A, Rodríguez-Molina JJ, Carreño L, Fernández-Cruz E.

Arthritis Rheum. 2006 Aug 15;55(4):657-61. No abstract available.

7.

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.

Van Steendam K, Tilleman K, Deforce D.

Rheumatology (Oxford). 2011 May;50(5):830-7. doi: 10.1093/rheumatology/keq419. Epub 2011 Jan 27. Review.

8.

A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.

Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.

J Rheumatol. 2011 Jul;38(7):1265-72. doi: 10.3899/jrheum.101086. Epub 2011 Apr 1.

PMID:
21459947
9.

Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis.

Sghiri R, Khalifa O, Bouajina E, Ben Haj Slama F, Baccouche K, Ben Fredj H, Gaha R, Boukadida J.

Joint Bone Spine. 2010 May;77(3):279-80. doi: 10.1016/j.jbspin.2010.02.007. Epub 2010 Apr 7. No abstract available.

PMID:
20378382
10.

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.

Al-Jarallah K, Shehab D, Al-Attiyah R, Al-Azmi W, Al-Fadli A, Zafar Haider M, Panaccione R, Ghosh S.

Inflamm Bowel Dis. 2012 Sep;18(9):1655-62. doi: 10.1002/ibd.21937. Epub 2011 Nov 23.

PMID:
22114016
11.

Somatic mutations and anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis: comment on the editorial by Levesque et al.

Firestein GS.

Arthritis Rheum. 2010 Jan;62(1):303-4. doi: 10.1002/art.27187. No abstract available.

12.

Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.

Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators.

Autoimmun Rev. 2012 Sep;11(11):815-20. doi: 10.1016/j.autrev.2012.02.015. Epub 2012 Feb 27.

PMID:
22394488
13.

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.

Ann Rheum Dis. 2009 May;68(5):736-43. doi: 10.1136/ard.2008.091355. Epub 2008 Jul 17.

PMID:
18635594
14.

Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.

Sghiri R, Bouajina E, Bargaoui D, Harzallah L, Fredj HB, Sammoud S, Ghedira I.

Rheumatol Int. 2008 Nov;29(1):59-62. doi: 10.1007/s00296-008-0614-8. Epub 2008 May 22.

PMID:
18496693
15.

Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.

Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U, Sengül A.

Protein Pept Lett. 2008;15(3):314-7.

PMID:
18336364
16.

Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.

Spadaro A, Riccieri V, Scrivo R, Alessandri C, Valesini G.

Arthritis Rheum. 2006 Aug 15;55(4):681-2; author reply 682. No abstract available.

17.

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.

18.

Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.

Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A.

Arthritis Rheum. 2010 Jan;62(1):117-25. doi: 10.1002/art.25059.

19.
20.

Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.

Montes A, Dieguez-Gonzalez R, Perez-Pampin E, Calaza M, Mera-Varela A, Gomez-Reino JJ, Gonzalez A.

Arthritis Rheum. 2011 Mar;63(3):654-61. doi: 10.1002/art.30186. Erratum in: Arthritis Rheum. 2011 Apr;63(4):938.

Supplemental Content

Support Center